Cadrenal Therapeutics Inc. Common Stock (CVKD) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Cadrenal Therapeutics Inc...

NASDAQ: CVKD · Real-Time Price · USD
14.31
0.12 (0.85%)
At close: Oct 03, 2025, 3:59 PM
14.36
0.35%
After-hours: Oct 03, 2025, 04:10 PM EDT

Cadrenal Therapeutics Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Cash & Equivalents
10.02M 8.4M 32.59K
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
3.79K 3.79K -526.01K
Receivables
38.15K n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
14.45K n/a 672.29K
Total Current Assets
10.11M 8.49M 727.6K
Property-Plant & Equipment
6.94K 23.29K 44.59K
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
10.74K 27.08K 50.58K
Total Assets
10.12M 8.52M 778.17K
Account Payables
1.5M 167.32K 404.9K
Deferred Revenue
n/a n/a n/a
Short-Term Debt
n/a n/a 43.73K
Other Current Liabilities
1.18M 596.13K 605.29K
Total Current Liabilities
2.68M 826.88K 1.33M
Long-Term Debt
n/a n/a 553.34K
Other Long-Term Liabilities
n/a n/a 4.42M
Total Long-Term Liabilities
n/a n/a 4.99M
Total Liabilities
2.68M 826.88K 6.33M
Total Debt
n/a 21.35K 640.71K
Book Value
7.44M 7.69M -5.55M
Book Value Per Share
6.10 8.86 -7.16
Common Stock
1.78K 13.02K 8.19K
Retained Earnings
-25.72M -15.07M -6.71M
Comprehensive Income
n/a n/a n/a
Shareholders Equity
7.44M 7.69M -5.55M
Total Investments
n/a n/a n/a